A study published Nov
Nutritional supplements and chronic disease: bridging the gap between myth and reality
One found evidence of altered plasma levels of carnitine and other metabolites
Daver NG, Garcia-Manero G, Basu S, Ravandi F, Kadia TM, Borthakur G, Jabbour E, DiNardo CD, Pemmaraju N, Brandt M, Pierce S, Hussin N, Kornblau SM, Andreeff M , Konopleva M, Ning J, Allison JP, Sharma P, Kantarjian HM
In late-stage trials, people taking orforglipron lost an average of about 12% of their body weight over roughly 72 weeks , and head-to-head studies suggest it may outperform standard oral semaglutide tablets (Rybelsus) in both weight loss and blood sugar control
The rate of weight gain after drug discontinuation was not dependent on the level of support provided during the period after medication discontinuation